Reduced Arginyltransferase 1 is a driver and a potential prognostic indicator of prostate cancer metastasis
Bioportfolio,
Related Biotechnology, Pharmaceutical and Healthcare News Original Article: NEXT ARTICLE More From BioPortfolio on "Reduced…
Reduced Arginyltransferase 1 is a driver and a potential prognostic indicator of prostate cancer metastasis
Overview of attention for article published in Oncogene, September 2018
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (84th percentile)
-
High Attention Score compared to outputs of the same age and source (84th percentile)
Readers on
- mendeley
- 31 Mendeley